Edmond S. K. Ma (0000-0002-1259-2205)

Personal information

Biography

Dr. Edmond Ma obtained his MBBS degree from the University of Hong Kong in 1987 and Doctor of Medicine degree in 2004. Dr. Ma is a specialist in Haematology and is currently the Director of Clinical and Molecular Pathology at Hong Kong Sanatorium & Hospital. He is Honorary Clinical Associate Professor at the Department of Pathology, The University of Hong Kong; and Clinical Associate Professor (Honorary) at the Department of Anatomical & Cellular Pathology, The Chinese University of Hong Kong. His clinical and research effort is focused on the application of genetics and genomics to advance personalised medical care. Dr. Ma is the Chairman of the Children’s Thalassaemia Foundation and the Chairman of the Working Party on Medical Genetics of Hong Kong Accreditation Service. He was past Vice-President and Chief Examiner in Haematology of the Hong Kong College of Pathologists, and Councilor of the International Society of Laboratory Haematology from 2014 to 2019. Dr Ma is an International Fellow of the American Society of Clinical Pathology, a Founding Fellow of the Faculty of Science, The Royal College of Pathologists of Australasia, and an Affiliate Member of both the College of American Pathologists and the American College of Medical Genetics and Genomics.

Activities

Collapse all

Hong Kong Sanatorium and Hospital: Hong Kong, HK

2005-01-01 to present | Director of Clinical & Molecular Pathology (Pathology)

Employment

Edmond S. K. Ma

https://orcid.org/0000-0002-1259-2205

Personal information

Other IDs

Countries

Biography

Activities

Employment (1)

Hong Kong Sanatorium and Hospital: Hong Kong, HK

Education and qualifications (8)

Royal College of Pathologists of Australasia: Surry Hills, NSW, AU

Royal College of Physicians and Surgeons of Glasgow: Glasgow, Glasgow, GB

Royal College of Physicians: London, London, GB

University of Hong Kong: Hong Kong, HK

Royal College of Pathologists: London, London, GB

Royal College of Physicians of Edinburgh: Edinburgh, Edinburgh, GB

Royal College of Pathologists of Australasia: Surry Hills, NSW, AU

University of Hong Kong: Hong Kong, HK

Professional activities (8)

American College of Medical Genetics and Genomics: Bethesda, MD, US

Children's Thalassaemia Foundation: Hong Kong, HK

International Society of Laboratory Haematology: Glenview, IL, US

Association for Molecular Pathology: Bethesda, MD, US

American Society for Clinical Pathology: Chicago, IL, US

American Society for Investigative Pathology: Bethesda, MD, US

College of American Pathologists: Northfield, IL, US

American Society of Hematology: Washington, DC, US

Works (50 of 230)

Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride

Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort

Germline RAD51C and RAD51D Mutations in High-Risk Chinese Breast and/or Ovarian Cancer Patients and Families

Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients

Clinical Evaluation of the BIOFIRE SPOTFIRE Respiratory Panel

Clinical Evaluation of Xpert Xpress CoV-2/Flu/RSV <i>plus</i> and Alinity m Resp-4-Plex Assay

Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies.

Distinct karyotypic and mutational landscape in trisomy AML.

Evaluation of a Commercial Point-of-Care RT-LAMP Assay for Rapid Detection of SARS-CoV-2

The Seasonality of Respiratory Viruses in a Hong Kong Hospital, 2014–2023

Occult intravascular large B-cell lymphoma presenting as postoperative thrombotic microangiopathy: a case report.

Consensus Statements on Precision Oncology in the China Greater Bay Area.

Effect on Germline Mutation Rate in a High-Risk Chinese Breast Cancer Cohort after Compliance with The National Comprehensive Cancer Network (NCCN) 2023 v.1 Testing Criteria

The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours.

Impact of COVID-19 Vaccination on Healthcare Worker Infection Rate and Outcome during SARS-CoV-2 Omicron Variant Outbreak in Hong Kong

Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody

Rapid Breakpoint Mapping of a Novel Germline PALB2 Duplication by PCR-Free Long-Read Sequencing for Interpretation of Its Pathogenicity

Germline <i>PALB2</i> Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients

A Case Report of Germline Compound Heterozygous Mutations in the <i>BRCA1</i> Gene of an Ovarian and Breast Cancer Patient

An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping.

Potential utility of targeted Nanopore sequencing for improving etiologic diagnosis of bacterial and fungal respiratory infection.

Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantation.

Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Potential utility of metagenomic sequencing for improving etiologic diagnosis of infective endocarditis.

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.

Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing.

Next-generation sequencing panel for diagnosis and management of chronic neutrophilic leukaemia: a case report.

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations.

Draft Genome Sequence of Helicobacter cinaedi, Compiled by Direct Whole-Genome Sequencing of a Blood Culture-Positive Isolate in Hong Kong.

Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma.

Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations.

Breast and ovarian cancer penetrance of BRCA1/2 mutations among Hong Kong women.

Prospective study on human fecal carriage of Enterobacteriaceae possessing mcr-1 and mcr-2 genes in a regional hospital in Hong Kong.

Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels.

Association analysis identifies 65 new breast cancer risk loci.

Next-generation sequencing and molecular cytogenetic characterization of ETV6-LYN fusion due to chromosomes 1, 8 and 12 rearrangement in acute myeloid leukemia.

BAMClipper: removing primers from alignments to minimize false-negative mutations in amplicon next-generation sequencing.

INDELseek: detection of complex insertions and deletions from next-generation sequencing data.

Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.

Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms

Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia.

Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma.

Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome.

Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next-Generation Sequencing on a Four-Gene Panel.

Clinical Evaluation of the New High-Throughput Luminex NxTAG Respiratory Pathogen Panel Assay for Multiplex Respiratory Pathogen Detection.

Germline RECQL mutations in high risk Chinese breast cancer patients.

Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.

Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries.

The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer.

Peer review (6 reviews for 4 publications/grants)